These findings suggest that KIAA1114 is a unique biomarker whose expression not only overlaps with diverse liver TIC markers, but also correlates with tumorigenic capacities of HCC cell lines in both AFP+ and AFP− subtypes. Here, TRO is linked to hepatocellular carcinoma.